Search

Search Constraints

You searched for: Author/Creator Sebert, Marie

Search Results

2. The transfusion of non‐prophylactically RH‐KEL1 antigen‐matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients. Issue 5 (5th January 2022)

3. Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM). Issue 14 (10th May 2021)

4. Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions. Issue 12 (14th October 2020)

5. Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast‐phase myeloproliferative neoplasms. (10th June 2015)

6. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. Issue 1 (1st January 2023)

7. Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities. Issue 10 (14th July 2015)